Financials
Income statement
Fiscal date | Jan 2025 | Oct 2024 | Apr 2024 | Jan 2024 |
---|---|---|---|---|
Total reported revenue | 0 | 0 | 0 | 0 |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 266.7K | 109.6K | 102.9K | 96.5K |
Other operating expenses | 64.0K | 34.7K | 112.2K | 64.4K |
Operating income | -330.7K | -144.2K | -215.1K | -160.9K |
Non operating interest income | ||||
Income | 24.7K | 12.4K | — | 0 |
Expense | — | — | — | — |
Other income expense | 40 | — | -11.2K | — |
Pretax income | -306.1K | -131.9K | -226.4K | -161.3K |
Tax provision | — | — | — | — |
Net income | -306.1K | -131.9K | -226.4K | -161.3K |
Basic EPS | 0.0 | 0.0 | — | 0.0 |
Diluted EPS | 0.0 | 0.0 | — | 0.0 |
Basic average shares | 129.7M | 129.7M | — | 129.7M |
Diluted average shares | 129.7M | 129.7M | — | 129.7M |
EBITDA | -330.8K | -144.2K | -203.9K | -160.9K |
Net income from continuing op. | -306.1K | — | -226.4K | -161.3K |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |